1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BIOINFORMATICS MARKET BY APPLICATION
5.1. Introduction
5.2. Drug Discovery and Development
5.3. Personalized and Preventive Medicine
5.4. Genomics and Genetic Research
5.5. Molecular Medicine
5.6. Clinical Diagnostics
5.7. Forensic and Environmental Bioinformatics
5.8. Others
6. BIOINFORMATICS MARKET BY BIOLOGICAL DATA TYPE
6.1. Introduction
6.2. Genomics
6.3. Transcriptomics
6.4. Proteomics
6.5. Metabolomics
6.6. Pharmacogenomics
6.7. Cheminformatics
6.8. Epigenomics
6.9. Others
7. BIOINFORMATICS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical and Biotechnology Companies
7.3. Academic and Research Institutes
7.4. Agricultural Research Organizations
7.5. Hospitals and Clinics
7.6. Contract Research Organizations (CROs)
7.7. Others
8. BIOINFORMATICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Application
8.2.2. By Biological Data Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Application
8.3.2. By Biological Data Type
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Application
8.4.2. By Biological Data Type
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Application
8.5.2. By Biological Data Type
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Application
8.6.2. By Biological Data Type
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. Illumina Inc.
10.3. QIAGEN N.V.
10.4. Agilent Technologies Inc.
10.5. PerkinElmer Inc.
10.6. Eurofins Scientific
10.7. DNAnexus Inc.
10.8. BGI Group
10.9. Waters Corporation
10.10. DNASTAR Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES